Golden State Equity Partners Haemonetics Corp Transaction History

Golden State Equity Partners

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Jun 01, 2023	SELL	$72.75 - $90.6 $863,033 - $1.07 Million	-11,863 Closed	0 $0
Q1 2022 May 18, 2022	BUY	$43.77 - $63.22 $519,243 - $749,978	11,863 New	11,863 $750,000
Q1 2022 May 16, 2022	SELL	$43.77 - $63.22 $519,243 - $749,978	-11,863 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$49.55 - $74.59 $31,563 - $47,513	637 Added 5.67%	11,863 $629,000
Q2 2021 Aug 12, 2021	BUY	$51.81 - $118.56 $581,619 - $1.33 Million	11,226 New	11,226 $748,000

332

53.8M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.97B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Golden State Equity Partners, based on Form 13F filings with the SEC.

Stay updated on Golden State Equity Partners with notifications on news.